BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21396837)

  • 21. Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy.
    Hansen J; Budäus L; Spethmann J; Schlomm T; Salomon G; Rink M; Haese A; Steuber T; Heinzer H; Huland H; Graefen M; Michl U
    Urology; 2012 Oct; 80(4):877-82. PubMed ID: 22950996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.
    Schiavina R; Borghesi M; Brunocilla E; Manferrari F; Fiorentino M; Vagnoni V; Baccos A; Pultrone CV; Rocca GC; Rizzi S; Martorana G
    BJU Int; 2013 Jun; 111(8):1237-44. PubMed ID: 23331345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic Involvement of the Prostatic Anterior Fat Pad: Implications for the Pathologist.
    Lopez-Hisijos N; Genco I; Gorbonos A; Pambuccian SE; Barkan GA
    Am J Clin Pathol; 2018 Jul; 150(2):130-136. PubMed ID: 29893778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience.
    Yates J; Haleblian G; Stein B; Miller B; Renzulli J; Pareek G
    Can J Urol; 2009 Oct; 16(5):4842-6. PubMed ID: 19796462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2000 Apr; 163(4):1183-8. PubMed ID: 10737491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of lymph nodes and metastasis within prostatic anterior fat pad in radical prostatectomy patients: A single Chinese institution experience and literature review.
    Hu M; Liao J; Cai W; Ling H; Wu D; Xu X; Zhu Q; Ye L
    Eur J Surg Oncol; 2023 Dec; 49(12):107112. PubMed ID: 37832178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
    BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases.
    Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B
    Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Algorithm for selecting men for pelvic lymph node dissection (PLND) during radical prostatectomy based on clinical risk factors in an Australian population.
    Sengupta S; Weerakoon M; Sethi K; Ischia J; Webb DR
    BJU Int; 2012 Apr; 109 Suppl 3():48-51. PubMed ID: 22458494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes.
    Boris RS; Bhandari A; Krane LS; Eun D; Kaul S; Peabody JO
    BJU Int; 2009 Apr; 103(7):952-6. PubMed ID: 19076132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of lymphadenectomy for prostate cancer: indications and controversies.
    La Rochelle JC; Amling CL
    Urol Clin North Am; 2011 Nov; 38(4):387-95, v. PubMed ID: 22045170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of prostatic anterior fat pads with lymph node staging in prostate cancer.
    Weng WC; Huang LH; Hsu CY; Tung MC; Yang CK; Jin JS; Ou YC; Yang SF
    J Cancer; 2018; 9(18):3361-3365. PubMed ID: 30271497
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.
    Mitsuzuka K; Narita S; Koie T; Kaiho Y; Tsuchiya N; Yoneyama T; Kakoi N; Kawamura S; Tochigi T; Habuchi T; Ohyama C; Arai Y
    BJU Int; 2013 May; 111(6):914-20. PubMed ID: 23320782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 years.
    Schostak M; Krause H; Miller K; Schrader M; Kempkensteffen C; Kollermann J
    BJU Int; 2007 Jun; 99(6):1409-14. PubMed ID: 17428244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy.
    Cooperberg MR; Kane CJ; Cowan JE; Carroll PR
    BJU Int; 2010 Jan; 105(1):88-92. PubMed ID: 19549119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early oncological outcomes of robot-assisted radical prostatectomy for high-grade prostate cancer.
    Wambi CO; Siddiqui SA; Krane LS; Agarwal PK; Stricker HJ; Peabody JO
    BJU Int; 2010 Dec; 106(11):1739-45. PubMed ID: 20575980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.